NMRA-215

N/A

Report date: 2025/09/05 17:57:25
NME

Base Information

Drug NameNMRA-215
Drug Alias NameNMRA-215
ClassificationSmall molecules
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsObesityParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeumora Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeumora Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsObesityParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A